Dupilumab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Asthma with Elevated Type 2 Biomarkers and Fixed Airflow Obstruction

Autor:	N.A. Hanania, M. Castro, E.D. Bateman, I.D. Pavord, A. Papi, J.M. FitzGerald, J.F. Maspero, C. Katelaris, D. Singh, N. Daizadeh, N. Pandit-Abid, B. Ortiz, E. Laws, J.A. Jacob-Nara, P.J. Rowe, Y. Deniz, D.J. Lederer, M. Hardin, S. Siddiqui
Rok vydání:	2022
Zdroj:	C101. EXPANDING THE USE OF ASTHMA BIOLOGICS AND OTHER NOVEL THERAPEUTICS TO ADDITIONAL PATIENT POPULATIONS.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::769810901ff46f200b2dfdcd2a280c33 https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a4843 Zobrazit plný text záznamu